PROBIOTEC LIMITED (PBP) operates in the Pharmaceuticals Biotechnology & Life Sciences industry category. Probiotec Limited manufactures, markets, and distributes a range of prescription and over-the-counter pharmaceuticals, complementary medicines, and specialty ingredients in Australia and internationally
The most recent ex-dividend date was 24-10-2019. This dividend was $0.025 and was fully franked. The date paid for this dividend is 31-10-2019.